‎Avalon Pharma secures CMA nod for 75% bonus capital boost

​‎

Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma)

The Capital Market Authority (CMA) approved Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) capital top-up request by 75% through a 3-for-4 bonus share issue, according to a statement to Tadawul.

Advertisement

‎

Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma)

The Capital Market Authority (CMA) approved Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) capital top-up request by 75% through a 3-for-4 bonus share issue, according to a statement to Tadawul.